Literature DB >> 19454463

Rectal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.

B Glimelius1, J Oliveira.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19454463     DOI： 10.1093/annonc/mdp128

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  15 in total

Review 1.  [Diagnosis and treatment of rectal cancer].

Authors:  Nicole Jacobi; Frank Gieseler
Journal:  Med Klin (Munich)       Date:  2010-10

2.  A retrospective review of 126 high-grade neuroendocrine carcinomas of the colon and rectum.

Authors:  James D Smith; Diane L Reidy; Karyn A Goodman; Jinru Shia; Garrett M Nash
Journal:  Ann Surg Oncol       Date:  2014-04-24       Impact factor: 5.344

3.  Silencing of the Wnt transcription factor TCF4 sensitizes colorectal cancer cells to (chemo-) radiotherapy.

Authors:  Emil Kendziorra; Kerstin Ahlborn; Melanie Spitzner; Margret Rave-Fränk; Georg Emons; Jochen Gaedcke; Frank Kramer; Hendrik A Wolff; Heinz Becker; Tim Beissbarth; Reinhard Ebner; B Michael Ghadimi; Tobias Pukrop; Thomas Ried; Marian Grade
Journal:  Carcinogenesis       Date:  2011-10-08       Impact factor: 4.944

4.  Addition of bevacizumab to XELOX induction therapy plus concomitant capecitabine-based chemoradiotherapy in magnetic resonance imaging-defined poor-prognosis locally advanced rectal cancer: the AVACROSS study.

Authors:  Miguel Nogué; Antonieta Salud; Pilar Vicente; Antonio Arriví; José María Roca; Ferran Losa; José Ponce; María José Safont; Inmaculada Guasch; Isabel Moreno; Ana Ruiz; Carles Pericay
Journal:  Oncologist       Date:  2011-04-05

5.  On biomarkers and pathways in rectal cancer: What's the target?

Authors:  Gabriele Zoppoli; Valter Ferrando; Stefano Scabini
Journal:  World J Gastrointest Surg       Date:  2012-12-27

6.  Role of radiation therapy in neoadjuvant era in patients with locally advanced rectal cancer.

Authors:  Georgios V Koukourakis
Journal:  World J Gastrointest Oncol       Date:  2012-12-15

Review 7.  Risk factors for local recurrence following neoadjuvant chemoradiotherapy for rectal cancers.

Authors:  Jia-Yuan Peng; Zhong-Nan Li; Yu Wang
Journal:  World J Gastroenterol       Date:  2013-08-28       Impact factor: 5.742

8.  Neoadjuvant chemoradiation with concomitant boost radiotherapy associated to capecitabine in rectal cancer patients.

Authors:  Mattia F Osti; Linda Agolli; Stefano Bracci; Luigi Masoni; Maurizio Valeriani; Teresa Falco; Vitaliana De Sanctis; Riccardo Maurizi Enrici
Journal:  Int J Colorectal Dis       Date:  2014-05-14       Impact factor: 2.571

9.  Is adjuvant chemotherapy necessary for patients with pathological complete response after neoadjuvant chemoradiotherapy and radical surgery in locally advanced rectal cancer? Long-term analysis of 40 ypCR patients at a single center.

Authors:  Jiaolin Zhou; Huizhong Qiu; Guole Lin; Yi Xiao; Bin Wu; Wenming Wu; Xiyu Sun; Junyang Lu; Guannan Zhang; Lai Xu; Yuchao Liu
Journal:  Int J Colorectal Dis       Date:  2016-04-05       Impact factor: 2.571

10.  Post-treatment surveillance in colorectal cancer.

Authors:  Vaneja Velenik
Journal:  Radiol Oncol       Date:  2010-09-09       Impact factor: 2.991
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.